Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.
about
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma.Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma CellsSuppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells
P2860
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Overriding TKI resistance of r ...... y with IL-6 receptor blockade.
@en
type
label
Overriding TKI resistance of r ...... y with IL-6 receptor blockade.
@en
prefLabel
Overriding TKI resistance of r ...... y with IL-6 receptor blockade.
@en
P2093
P2860
P356
P1433
P1476
Overriding TKI resistance of r ...... y with IL-6 receptor blockade.
@en
P2093
Dirk Prawitt
Hiroyuki Hiraki
Hitoshi Kubo
Ines Breuksch
Joachim W Thüroff
Junya Hata
Kei Ishibashi
Masao Kataoka
Michihiro Yabe
Nobuhiro Haga
P2860
P304
55230-55245
P356
10.18632/ONCOTARGET.19420
P407
P577
2017-07-21T00:00:00Z